Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Ventripoint Diagnostics Ltd (VPT.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in thousands)

	12-2024	12-2023	12-2022	12-2021	12-2020
Cash Flows From Operating Activities
Depreciation Amortization	63	67	51	49	55
Income taxes - deferred	-83	N/A	N/A	N/A	N/A
Accounts receivable	34	89	-177	-32	-98
Accounts payable and accrued liabilities	N/A	285	-87	-396	146
Other Working Capital	699	452	-331	-463	123
Other Operating Activity	-4,099	-4,697	-3,593	-2,305	-1,326
Operating Cash Flow	$-3,386	$-3,804	$-4,137	$-3,147	$-1,100

Cash Flows From Investing Activities
PPE Investments	N/A	N/A	0	-4	-4
Investing Cash Flow	$N/A	$N/A	$0	$-4	$-4

Cash Flows From Financing Activities
Change In Short Term Borrowing	1,675	N/A	N/A	N/A	N/A
Debt Issued	N/A	N/A	N/A	0	1,000
Debt Repayment	-158	-102	-51	-49	-13
Common Stock Issued	555	N/A	0	8,055	N/A
Other Financing Activity	128	0	138	3,884	634
Financing Cash Flow	$2,200	$-102	$88	$11,890	$1,621

Exchange Rate Effect	-48	15	-34	3	-5
Beginning Cash Position	1,294	5,186	9,269	526	14
End Cash Position	61	1,294	5,186	9,269	526
Net Cash Flow	$-1,186	$-3,906	$-4,049	$8,739	$517

Free Cash Flow
Operating Cash Flow	-3,386	-3,804	-4,137	-3,147	-1,100
Capital Expenditure	N/A	N/A	N/A	-4	-4
Free Cash Flow	-3,386	-3,804	-4,137	-3,151	-1,104